APO RESEARCH · REPORT
Soliris
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Product & engineering
Understand the product.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Selected research
Market Analysis & Forecast
Global Soliris Market Analysis and Forecast 2026-2032
Market perspective
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.
Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.
Read the full market overview
This report presents an overview of global market for Soliris, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Soliris, also provides the sales of main regions and countries. Of the upcoming market potential for Soliris, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Soliris sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Soliris market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Soliris sales, projected growth trends, production technology, application and end-user industry.
Soliris Segment by Company
Alexion
Soliris Segment by Type
Plasma Exchange
Plasma Infusion
Soliris Segment by Application
PNH
aHUS
Other
Soliris Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soliris market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Soliris and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soliris.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Soliris in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Soliris manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Soliris sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasma Exchange
- Plasma Infusion
Applications
- PNH
- aHUS
- Other
Companies covered
- Alexion
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Soliris Market by Type
- 1.2.1 Global Soliris Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Plasma Exchange
- 1.2.3 Plasma Infusion
- 1.3 Soliris Market by Application
- 1.3.1 Global Soliris Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 PNH
- 1.3.3 aHUS
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Soliris Market Dynamics
- 2.1 Soliris Industry Trends
- 2.2 Soliris Industry Drivers
- 2.3 Soliris Industry Opportunities and Challenges
- 2.4 Soliris Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Soliris Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Soliris Revenue by Region
- 3.2.1 Global Soliris Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Soliris Revenue by Region (2021-2026)
- 3.2.3 Global Soliris Revenue by Region (2027-2032)
- 3.2.4 Global Soliris Revenue Market Share by Region (2021-2032)
- 3.3 Global Soliris Sales Estimates and Forecasts 2021-2032
- 3.4 Global Soliris Sales by Region
- 3.4.1 Global Soliris Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Soliris Sales by Region (2021-2026)
- 3.4.3 Global Soliris Sales by Region (2027-2032)
- 3.4.4 Global Soliris Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Soliris Revenue by Manufacturers
- 4.1.1 Global Soliris Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Soliris Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Soliris Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Soliris Sales by Manufacturers
- 4.2.1 Global Soliris Sales by Manufacturers (2021-2026)
- 4.2.2 Global Soliris Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Soliris Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Soliris Sales Price by Manufacturers (2021-2026)
- 4.4 Global Soliris Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Soliris Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Soliris Manufacturers, Product Type & Application
- 4.7 Global Soliris Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Soliris Market CR5 and HHI
- 4.8.2 2025 Soliris Tier 1, Tier 2, and Tier 3
5 Soliris Market by Type
- 5.1 Global Soliris Revenue by Type
- 5.1.1 Global Soliris Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Soliris Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Soliris Revenue Market Share by Type (2021-2032)
- 5.2 Global Soliris Sales by Type
- 5.2.1 Global Soliris Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Soliris Sales by Type (2021-2032) & (Unit)
- 5.2.3 Global Soliris Sales Market Share by Type (2021-2032)
- 5.3 Global Soliris Price by Type
6 Soliris Market by Application
- 6.1 Global Soliris Revenue by Application
- 6.1.1 Global Soliris Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Soliris Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Soliris Revenue Market Share by Application (2021-2032)
- 6.2 Global Soliris Sales by Application
- 6.2.1 Global Soliris Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Soliris Sales by Application (2021-2032) & (Unit)
- 6.2.3 Global Soliris Sales Market Share by Application (2021-2032)
- 6.3 Global Soliris Price by Application
7 Company Profiles
- 7.1 Alexion
- 7.1.1 Alexion Company Information
- 7.1.2 Alexion Business Overview
- 7.1.3 Alexion Soliris Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Alexion Soliris Product Portfolio
- 7.1.5 Alexion Recent Developments
8 North America
- 8.1 North America Soliris Market Size by Type
- 8.1.1 North America Soliris Revenue by Type (2021-2032)
- 8.1.2 North America Soliris Sales by Type (2021-2032)
- 8.1.3 North America Soliris Price by Type (2021-2032)
- 8.2 North America Soliris Market Size by Application
- 8.2.1 North America Soliris Revenue by Application (2021-2032)
- 8.2.2 North America Soliris Sales by Application (2021-2032)
- 8.2.3 North America Soliris Price by Application (2021-2032)
- 8.3 North America Soliris Market Size by Country
- 8.3.1 North America Soliris Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Soliris Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Soliris Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Soliris Market Size by Type
- 9.1.1 Europe Soliris Revenue by Type (2021-2032)
- 9.1.2 Europe Soliris Sales by Type (2021-2032)
- 9.1.3 Europe Soliris Price by Type (2021-2032)
- 9.2 Europe Soliris Market Size by Application
- 9.2.1 Europe Soliris Revenue by Application (2021-2032)
- 9.2.2 Europe Soliris Sales by Application (2021-2032)
- 9.2.3 Europe Soliris Price by Application (2021-2032)
- 9.3 Europe Soliris Market Size by Country
- 9.3.1 Europe Soliris Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Soliris Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Soliris Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Soliris Market Size by Type
- 10.1.1 China Soliris Revenue by Type (2021-2032)
- 10.1.2 China Soliris Sales by Type (2021-2032)
- 10.1.3 China Soliris Price by Type (2021-2032)
- 10.2 China Soliris Market Size by Application
- 10.2.1 China Soliris Revenue by Application (2021-2032)
- 10.2.2 China Soliris Sales by Application (2021-2032)
- 10.2.3 China Soliris Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Soliris Market Size by Type
- 11.1.1 Asia Soliris Revenue by Type (2021-2032)
- 11.1.2 Asia Soliris Sales by Type (2021-2032)
- 11.1.3 Asia Soliris Price by Type (2021-2032)
- 11.2 Asia Soliris Market Size by Application
- 11.2.1 Asia Soliris Revenue by Application (2021-2032)
- 11.2.2 Asia Soliris Sales by Application (2021-2032)
- 11.2.3 Asia Soliris Price by Application (2021-2032)
- 11.3 Asia Soliris Market Size by Country
- 11.3.1 Asia Soliris Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Soliris Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Soliris Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Soliris Market Size by Type
- 12.1.1 SAMEA Soliris Revenue by Type (2021-2032)
- 12.1.2 SAMEA Soliris Sales by Type (2021-2032)
- 12.1.3 SAMEA Soliris Price by Type (2021-2032)
- 12.2 SAMEA Soliris Market Size by Application
- 12.2.1 SAMEA Soliris Revenue by Application (2021-2032)
- 12.2.2 SAMEA Soliris Sales by Application (2021-2032)
- 12.2.3 SAMEA Soliris Price by Application (2021-2032)
- 12.3 SAMEA Soliris Market Size by Country
- 12.3.1 SAMEA Soliris Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Soliris Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Soliris Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Soliris Value Chain Analysis
- 13.1.1 Soliris Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Soliris Production Mode & Process
- 13.2 Soliris Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Soliris Distributors
- 13.2.3 Soliris Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst